Billiontoone (NASDAQ:BLLN) SVP Bosch John Roderick Ten Sells 1,416 Shares

by · The Cerbat Gem

Billiontoone, Inc. (NASDAQ:BLLN – Get Free Report) SVP Bosch John Roderick Ten sold 1,416 shares of Billiontoone stock in a transaction on Monday, September 21st. The shares were sold at an average price of $106.61, for a total value of $150,959.76. Following the transaction, the senior vice president directly owned 23,635 shares of the company’s stock, valued at approximately $2,519,727.35. The trade was a 5.65% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Bosch John Roderick Ten also recently made the following trade(s):

  • On Wednesday, September 9th, Bosch John Roderick Ten sold 1,416 shares of Billiontoone stock. The shares were sold at an average price of $97.54, for a total transaction of $138,116.64.
  • On Tuesday, August 25th, Bosch John Roderick Ten sold 1,417 shares of Billiontoone stock. The stock was sold at an average price of $100.00, for a total transaction of $141,700.00.
  • On Monday, August 10th, Bosch John Roderick Ten sold 1,417 shares of Billiontoone stock. The stock was sold at an average price of $92.86, for a total transaction of $131,582.62.
  • On Monday, June 29th, Bosch John Roderick Ten sold 1,416 shares of Billiontoone stock. The shares were sold at an average price of $120.00, for a total transaction of $169,920.00.

Billiontoone Price Performance

NASDAQ:BLLN traded down $1.65 on Wednesday, reaching $114.42. The stock had a trading volume of 397,672 shares, compared to its average volume of 550,296. The company has a market capitalization of $5.40 billion and a P/E ratio of 163.46. Billiontoone, Inc. has a 1-year low of $61.96 and a 1-year high of $150.44. The company has a quick ratio of 11.31, a current ratio of 11.69 and a debt-to-equity ratio of 0.17. The stock has a fifty day moving average price of $109.25 and a 200-day moving average price of $97.49.

Billiontoone (NASDAQ:BLLN – Get Free Report) last posted its quarterly earnings data on Wednesday, August 5th. The company reported $0.15 earnings per share for the quarter, hitting the consensus estimate of $0.15. Billiontoone had a net margin of 8.04% and a return on equity of 9.96%. The company had revenue of $109.45 million during the quarter. Research analysts forecast that Billiontoone, Inc. will post 0.83 EPS for the current year.

Analysts Set New Price Targets

A number of equities research analysts recently weighed in on the company. Canaccord Genuity Group assumed coverage on Billiontoone in a report on Wednesday, September 2nd. They set a “buy” rating and a $120.00 price target for the company. Guggenheim began coverage on Billiontoone in a report on Monday, June 29th. They set a “buy” rating and a $125.00 target price on the stock. BTIG Research lowered their target price on Billiontoone from $142.00 to $130.00 and set a “buy” rating for the company in a research note on Thursday, August 6th. Weiss Ratings reiterated a “sell (d+)” rating on shares of Billiontoone in a research report on Friday. Finally, Zacks Research lowered shares of Billiontoone from a “hold” rating to a “strong sell” rating in a report on Monday, August 31st. Seven investment analysts have rated the stock with a Buy rating, two have given a Hold rating and two have issued a Sell rating to the stock. Based on data from MarketBeat, Billiontoone currently has an average rating of “Hold” and an average price target of $125.88.

Read Our Latest Research Report on BLLN

Institutional Inflows and Outflows

Institutional investors have recently bought and sold shares of the stock. Adams Street Partners LLC bought a new position in Billiontoone in the 4th quarter valued at $140,063,000. Wasatch Advisors LP bought a new stake in shares of Billiontoone during the first quarter worth $29,179,000. Capital International Investors bought a new stake in shares of Billiontoone during the fourth quarter worth $14,568,000. Renaissance Technologies LLC acquired a new position in shares of Billiontoone during the first quarter valued at $4,046,000. Finally, Emerald Advisers LLC boosted its holdings in Billiontoone by 26.8% in the first quarter. Emerald Advisers LLC now owns 239,562 shares of the company’s stock valued at $18,911,000 after acquiring an additional 50,613 shares during the last quarter.

Billiontoone Company Profile

(Get Free Report)

BillionToOne, Inc is a molecular diagnostics company that develops blood-based tests designed to provide genetic and health information from small amounts of biological material. The company’s technology uses its proprietary quantitative counting template approach to improve the accuracy and sensitivity of molecular testing.

The company’s primary offerings include UNITY, a portfolio of prenatal genetic tests. These services support screening for chromosomal conditions, single-gene disorders and carrier status, and are designed to help healthcare providers assess fetal and maternal genetic risks using a maternal blood sample.

Featured Articles